North Dakota · G0328

Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in North Dakota

North Dakota Medicare Avg
$17.52
1% below national avg
National Medicare Avg
$17.63
All states combined
Billed Charge (ND)
$60.22
What providers submit
Est. Commercial (ND)
$35.04
National avg: $39.49
Est. Cash / Self-Pay (ND)
$29.70
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

105
Services in ND
22
Providers
N/A
Min Payment
N/A
Max Payment

North Dakota Pricing in Context

In North Dakota, CPT code G0328 (Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous) carries an average Medicare payment of $17.52 — 1% below the national benchmark of $17.63. 22 providers across the state submitted claims for this procedure in 2023, performing 105 total services. Individual payments in ND ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Dakota is $60.22, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Dakota sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in North Dakota lands near $35.04, with self-pay cash prices typically around $29.70. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost in North Dakota?

The average Medicare payment for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in North Dakota is $17.52, which is 1% below the national average of $17.63. Providers in ND typically bill $60.22 for this procedure.

What does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost with insurance in North Dakota?

With commercial insurance in North Dakota, Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs an estimated $35.04. Without insurance, the estimated cash price is $29.70. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in North Dakota?

22 providers in North Dakota billed Medicare for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in 2023, performing 105 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cheaper in North Dakota than the national average?

Yes — Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs 1% below the national average in North Dakota. The state average Medicare payment is $17.52 compared to $17.63 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial